羧胺三唑抗炎作用及作用机制的初步研究
|
摘要
研究目的:
羧胺三唑(Carboxyamido-triazole,CAI)是一个主要由美国国家癌症中心研究的非细胞毒类抗肿瘤新药,在美国已进行过若干实验室和临床研究,其抗肿瘤特性已经得到证实。我们实验室发现羧胺三唑的抗癌作用可能与其细胞周期特异的抑制作用有关,同时发现其具有抗炎作用。本文将进一步证明其抗炎作用,同时以巨噬细胞为对象,研究其抗炎机理,并希望找到羧胺三唑在抗炎和抗肿瘤作用机理中的共同点。
研究内容:
1.建立大鼠佐剂性关节炎模型,检测CAI对在该慢性炎症模型上的抗炎表现。
2.以体外培养的大鼠肺泡巨噬细胞系(NR8383)为对象,用脂多糖(LPS)诱导建立炎症模型,检测CAI对其上清中TNF-α,IL-1β和NO的影响,并进一步检测相关信号通路中典型蛋白含量的变化。
研究方法:
本文采用大鼠佐剂性关节炎模型来检测羧胺三唑对慢性炎症和免疫性炎症的作用;采用体外培养的大鼠肺泡巨噬细胞系NR8383经LPS刺激后,加入CAI(10μmol.L~(-1(,401×mol.L~(-1))用酶联免疫吸附法(ELISA)检测细胞上清中TNF-α、NO和IL-1β的水平,用Western blot检测细胞裂解物中IκBα,磷酸化IκBα,和磷酸化JNK蛋白含量的变化。
研究结果:
1.在0.1 ml完全弗氏佐剂诱导的佐剂性关节炎模型中,20 mg/kg羧胺三唑可以抑制佐剂性关节炎大鼠的原发病变足和继发病变足的足趾肿胀度,与PEG400溶剂对照组相比,有显著差异(P＜0.05,P＜0.01)。
2.10和40μmol·L~(-1)的羧胺三唑都能降低LPS刺激的NR8383细胞系上清中一氧化氮的含量,使NO含量从33.63±0.801amol·L~(-1)分别降至5.11±0和4.43±0.32μmol·L~(-1),抑制率分别达到84.8%和86.8%,与DMSO溶剂对照组相比,有显著差异(P＜0.01)。
3.40μmol·L~(-1)的羧胺三唑能降低LPS刺激的NR8383细胞系上清中TNF-α的含量,使TNF-α含量从224.03±8.94 pg·ml~(-1)降至185.5±8.53 pg·ml~(-1),抑制率达到17.2%,与DMSO溶剂对照组相比,有显著差异(P＜0.05)。
4.10和40μmol·L~(-1)的羧胺三唑都能降低LPS刺激的NR8383细胞系上清中IL-1β的含量,使IL-1β含量从31.97±3.14 pg·ml~(-1)分别降至13.5±0.98和8.43±0.34pg·ml~(-1),抑制率分别达到57.8%和73.6%,与DMSO溶剂对照组相比,有显著差异(P＜0.05,P＜0.01)。
5.10和40μmol·L~(-1)的羧胺三唑对LPS刺激的NR8383细胞系中IκBα,磷酸化IκBα,和磷酸化JNK蛋白含量没有明显影响。
结论:
羧胺三唑有抗炎作用,其作用机制可能与抑制巨噬细胞分泌TNF-α、IL-1β和NO等炎症因子有关。但该抑制作用可能不是通过抑制NF-κB和JNK信号通路的激活来实现的。
OBJECTIVE:
Carboxyamido-triazole(CAI) is an experimental anti-cancer agent developed by National Institute of Cancer(NCI) of National Institutes of Health(NIH) of the United States of American.The anti-cancer effects of CAI have been proved by many preclinical experiments and several clinical trails in different stages carried out in the United States.We have found the mechanism of CAI's anti-tumor effect may be associated with inhibition of cell cycle.Meanwhile,we found CAI has a effect of anti-inflammatory.In this paper,we will prove the anti-inflammatory effect of CAI,and research the mechanism in macrophage.Base on these datas we hope to find the same target between anti-tumor and anti-inflammatory effects.
Contents:
1.Evaluate the effect of CAI on chronic inflammation and immunity inflammation in adjuvant-induced arthritis rat model.
2.Use the model of lipopolysaccharide(LPS) stimulated rat alveolar macrophage cell line(NRg383),test the inhibition effect of CAI on TNF-α,IL-1βand NO.And then observe the different in cell signal pathway.
Methods:
This study adopted adjuvant-induced arthritis rat model to evaluate the effect of CAI on chronic inflammation and immunity inflammation;this study cultured NR8383 cells were stimulated by LPS,added CAI,then use enzyme-linked immunosorbent assay (ELISA) to detect cell supematant TNF-α,NO and IL-1βlevels,and Western blot to detect celt lysates of IκBα,phosphorylated IκBα,and phosphorylated JNK content changes.
Results:
1.CAI inhibited the primary lesions and secondary lesions of AIA rats at 20 mg/kg,significantly(compare with PEG400 control group,P＜0.05,P＜0.01).
2.CAI at 10 and 40μmol·L~(-1) both decreased the levels of NO in supematant of NR8383 cell line stimulated by LPS.The level of NO for the DMSO control group was found to be 33.63±0.80μmol·L~(-1).Treatment with CAI at 10 and 40μmol·L~(-1) decreased the levels to 5.11±0 and 4.43±0.32μmol·L~(-1),respectively.The inhibitory rate are 84.8% and 86.8%,respectively.(P＜0.01)
3.CAI at 40μmol·L~(-1) both decreased the levels of TNF-αin supernatant of NR8383 cell line stimulated by LPS.The level of TNF-αfor the DMSO control group was found to be 224.03±8.94 pg·ml~(-1).Treatment with CAI at 40μmol·L~(-1) decreased the levels to 185.5±8.53 pg·ml~(-1).The inhibitory rate is 17.2%.(P＜0.05)
4.CAI at 10 and 40μmol·L~(-1) both decreased the levels of IL-1βin supernatant of NR8383 cell line stimulated by LPS.The level of IL-1βfor the DMSO control group was found to be 31.97±3.14 pg·ml~(-1).Treatment with CAI at 10 and 40μmol·L~(-1) decreased the levels to 13.5±0.9 and 8.43±0.34 pg·ml~(-1),respectively.The inhibitory rate are 57.8 and 73.6%,respectively.(P＜0.05,P＜0.01)
5.CAI at 10 and 40μmol·L~(-1) have no significant effect on IκBα,phosphorylated IκBα, and phosphorylated JNK in which NR8383 cell line stimulated by LPS.
Conclusion:
CAI can probably play an anti-inflammatory effect via inhibiting cytokines NO,IL-1βand TNF-α,but not acting on the NF-κβand JNK such classical signaling pathways.
羧胺三唑(Carboxyamido-triazole,CAI)是一个主要由美国国家癌症中心研究的非细胞毒类抗肿瘤新药,在美国已进行过若干实验室和临床研究,其抗肿瘤特性已经得到证实。我们实验室发现羧胺三唑的抗癌作用可能与其细胞周期特异的抑制作用有关,同时发现其具有抗炎作用。本文将进一步证明其抗炎作用,同时以巨噬细胞为对象,研究其抗炎机理,并希望找到羧胺三唑在抗炎和抗肿瘤作用机理中的共同点。
研究内容:
1.建立大鼠佐剂性关节炎模型,检测CAI对在该慢性炎症模型上的抗炎表现。
2.以体外培养的大鼠肺泡巨噬细胞系(NR8383)为对象,用脂多糖(LPS)诱导建立炎症模型,检测CAI对其上清中TNF-α,IL-1β和NO的影响,并进一步检测相关信号通路中典型蛋白含量的变化。
研究方法:
本文采用大鼠佐剂性关节炎模型来检测羧胺三唑对慢性炎症和免疫性炎症的作用;采用体外培养的大鼠肺泡巨噬细胞系NR8383经LPS刺激后,加入CAI(10μmol.L~(-1(,401×mol.L~(-1))用酶联免疫吸附法(ELISA)检测细胞上清中TNF-α、NO和IL-1β的水平,用Western blot检测细胞裂解物中IκBα,磷酸化IκBα,和磷酸化JNK蛋白含量的变化。
研究结果:
1.在0.1 ml完全弗氏佐剂诱导的佐剂性关节炎模型中,20 mg/kg羧胺三唑可以抑制佐剂性关节炎大鼠的原发病变足和继发病变足的足趾肿胀度,与PEG400溶剂对照组相比,有显著差异(P＜0.05,P＜0.01)。
2.10和40μmol·L~(-1)的羧胺三唑都能降低LPS刺激的NR8383细胞系上清中一氧化氮的含量,使NO含量从33.63±0.801amol·L~(-1)分别降至5.11±0和4.43±0.32μmol·L~(-1),抑制率分别达到84.8%和86.8%,与DMSO溶剂对照组相比,有显著差异(P＜0.01)。
3.40μmol·L~(-1)的羧胺三唑能降低LPS刺激的NR8383细胞系上清中TNF-α的含量,使TNF-α含量从224.03±8.94 pg·ml~(-1)降至185.5±8.53 pg·ml~(-1),抑制率达到17.2%,与DMSO溶剂对照组相比,有显著差异(P＜0.05)。
4.10和40μmol·L~(-1)的羧胺三唑都能降低LPS刺激的NR8383细胞系上清中IL-1β的含量,使IL-1β含量从31.97±3.14 pg·ml~(-1)分别降至13.5±0.98和8.43±0.34pg·ml~(-1),抑制率分别达到57.8%和73.6%,与DMSO溶剂对照组相比,有显著差异(P＜0.05,P＜0.01)。
5.10和40μmol·L~(-1)的羧胺三唑对LPS刺激的NR8383细胞系中IκBα,磷酸化IκBα,和磷酸化JNK蛋白含量没有明显影响。
结论:
羧胺三唑有抗炎作用,其作用机制可能与抑制巨噬细胞分泌TNF-α、IL-1β和NO等炎症因子有关。但该抑制作用可能不是通过抑制NF-κB和JNK信号通路的激活来实现的。
OBJECTIVE:
Carboxyamido-triazole(CAI) is an experimental anti-cancer agent developed by National Institute of Cancer(NCI) of National Institutes of Health(NIH) of the United States of American.The anti-cancer effects of CAI have been proved by many preclinical experiments and several clinical trails in different stages carried out in the United States.We have found the mechanism of CAI's anti-tumor effect may be associated with inhibition of cell cycle.Meanwhile,we found CAI has a effect of anti-inflammatory.In this paper,we will prove the anti-inflammatory effect of CAI,and research the mechanism in macrophage.Base on these datas we hope to find the same target between anti-tumor and anti-inflammatory effects.
Contents:
1.Evaluate the effect of CAI on chronic inflammation and immunity inflammation in adjuvant-induced arthritis rat model.
2.Use the model of lipopolysaccharide(LPS) stimulated rat alveolar macrophage cell line(NRg383),test the inhibition effect of CAI on TNF-α,IL-1βand NO.And then observe the different in cell signal pathway.
Methods:
This study adopted adjuvant-induced arthritis rat model to evaluate the effect of CAI on chronic inflammation and immunity inflammation;this study cultured NR8383 cells were stimulated by LPS,added CAI,then use enzyme-linked immunosorbent assay (ELISA) to detect cell supematant TNF-α,NO and IL-1βlevels,and Western blot to detect celt lysates of IκBα,phosphorylated IκBα,and phosphorylated JNK content changes.
Results:
1.CAI inhibited the primary lesions and secondary lesions of AIA rats at 20 mg/kg,significantly(compare with PEG400 control group,P＜0.05,P＜0.01).
2.CAI at 10 and 40μmol·L~(-1) both decreased the levels of NO in supematant of NR8383 cell line stimulated by LPS.The level of NO for the DMSO control group was found to be 33.63±0.80μmol·L~(-1).Treatment with CAI at 10 and 40μmol·L~(-1) decreased the levels to 5.11±0 and 4.43±0.32μmol·L~(-1),respectively.The inhibitory rate are 84.8% and 86.8%,respectively.(P＜0.01)
3.CAI at 40μmol·L~(-1) both decreased the levels of TNF-αin supernatant of NR8383 cell line stimulated by LPS.The level of TNF-αfor the DMSO control group was found to be 224.03±8.94 pg·ml~(-1).Treatment with CAI at 40μmol·L~(-1) decreased the levels to 185.5±8.53 pg·ml~(-1).The inhibitory rate is 17.2%.(P＜0.05)
4.CAI at 10 and 40μmol·L~(-1) both decreased the levels of IL-1βin supernatant of NR8383 cell line stimulated by LPS.The level of IL-1βfor the DMSO control group was found to be 31.97±3.14 pg·ml~(-1).Treatment with CAI at 10 and 40μmol·L~(-1) decreased the levels to 13.5±0.9 and 8.43±0.34 pg·ml~(-1),respectively.The inhibitory rate are 57.8 and 73.6%,respectively.(P＜0.05,P＜0.01)
5.CAI at 10 and 40μmol·L~(-1) have no significant effect on IκBα,phosphorylated IκBα, and phosphorylated JNK in which NR8383 cell line stimulated by LPS.
Conclusion:
CAI can probably play an anti-inflammatory effect via inhibiting cytokines NO,IL-1βand TNF-α,but not acting on the NF-κβand JNK such classical signaling pathways.
引文
Alberto Mantovani, Chiara Porta, Luca Rubino, Paola Allavena,Antonio Sica.2006.Tumor-associated macrophages (TAMs) as new target in anticancer therapy. Drug Discovery Today: Therapeutic Strategies , Vol. 3, No. 3:361-366.
Anfernee Kai-Wing Tse, Chi-Keung Wan, Xiao-Ling Shen, Mengsu Yang,Wang-Fun Fong.2005. Honokiol inhibits TNF-α-stimulated NF-κB activation and NF-κB regulated gene expression through suppression of IKK activation. Biochemical Pharmacology 70 (2005) 1443-1457.
Altomonte L, Zoli A, Mirone L. Serum levels of interleukin-1β,tumour necrosis factor-α and interleukin-2 in rheumatoid arthritis. Correlation with disease actibity[J].Clin Rheumatol, 1992,11(2); 202-5.
Amin Majdalawieh, Lei Zhang, and Hyo-Sung Ro.2007. Adipocyte Enhancer-binding Protein-1 Promotes Macrophage Inflammatory Responsiveness by Up-Regulating NF-κB via IκBα Negative Regulation Molecular Biology of the CellVol. 18, 930-942.
Bauer KS, Figg WD, Hamilton JM, Jones EC, Premkumar A, Steinberg SM, Dyer V, Linehan WM, Pluda JM, and Reed E. A pharmacokinetically guided Phase II study of carboxyamido-triazole in androgen-independent prostate cancer. Clin Cancer Res. 1999; 5(9): 2324-2329.
Bauer KS, Cude KJ, Dixon SC, Kruger EA, and Figg WD. Carboxyamido-triazole inhibits angiogenesis by blocking the calcium-mediated nitric-oxide synthase-vascular endothelial growth factor pathway. J. Pharmacol. Exp. Ther. 2000; 292(1): 31-37.
Brennan FM, Maini RN, Feldmann M. Role of pro-inflammatory cytokines in rheumatoid arthritis[J]. Springer Semin Immunopathol, 1998, 20:133-47.
Bredt, D.S. and Snyder, S.H. 1994. Nitric oxide: A physiologic messenger molecule.Ann. Rev. Biochem. 63, 175-95.
Bingle, L., Brown, N. J., and Lewis, C. E. 2002. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol. 196, 254-265.
Bonizzi G, Karin M .2004.The two NF-kappaa activation pathways and their rolein innateand adaptiveimmunity. TrendsInuntmol, 25(6): 280-288.
Bin Liu,Randy Yang, Kelly A. Wong, Crescent Getman,Natalie Stein, Michael A.Teitell,Genhong Cheng, Hong Wu, and Ke Shuai. 2005.Negative Regulation of NF-κB Signaling by PIAS1MOLECULAR AND CELLULAR BIOLOGY, p.1113-1123.
Balkwill F,Mantovani A.2001.Inflammation and cancer:back to Virchow?Lancet,357(9255):539-545.
Coussens LM,Werb Z.2002.Inflammation and cancer.Nature,420(6917):860-867.
Colorado A, Slama JT, Stavinoha WB. A new method for measuring auricular inflammation in the mouse. J Pharmacol Meth 1991,26:73-77.
Chun-Chung Lee, Ko-Jiunn Liu, Li-Li Chen, Yu-Chen Wu, and Tze-Sing Huang.2006. Tumor Necrosis Factor-α, Interleukin-8 and Interleukin-6 Are Involved in Vascular Endothelial Cell Capillary Tube and Network Formation Induced by Tumor-Associated Macrophages Lee et al. J. Cancer Mol. 2(4): 155-160.
Catrin Albrecht, Doris H¨ohr, Petra Haberzettl, and Andrea Becker.2007.Surface-Dependent Quartz Uptake by Macrophages:Potential Role in Pulmonary Inflammation and Lung Clearance. Inhalation Toxicology, 19(Suppl. 1):39—48.
Collart, M.A., Baeuerle, P., Vassalli, P., 1990. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four Kappa B-like motifs and of constitutive and inducible forms of NF-kappa B.Mol. Cell. Biol. 10, 1498-1506.
Christopher Brightling, PhD, MRCP,Mike Berry, MD, MRCP,and Yassine Amrani,PhD.2008. Targeting TNF-a: A novel therapeutic approach for asthma. J Allergy Clin Immunol; 121:5-10.
Dawson, T.M. and Dawson, V.L. 1995. Nitric oxide: Actions and pathological roles. The Neuroscientist 1, 7-18.
De＇rijard, B., Hibi, M., Wu, I.H., Barrett, T., Su, B., Deng, T., Karin, M.,Davis, R.J., 1994. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell ,76, 1025- 1037.
Denholm EM , Rollins SM . 1993.Expression and secretion of transforming growth factor-beta by bleomycin-stimulated rat alveolar macrophages. Am. J. Physiol. 264:L36-L42.
Dayer JM. Interleukin 1 or tumor necrosis factor-alpha: which is the real target in rheumatoid arthritis? J Rheumatol Suppl. 2002 Sep;65:10-5.
Fiddler, R.M. 1977 Collaborative study of modified AOAC method of analysis for nitrite in meat and meat products. J. AOAC 60, 594-9.
Geist, L.J., Powers, L.S., Monick, M.M., Hunninghake, G.W., 2000. Asbestos stimulation triggers differential cytokine release from human monocytes and alveolar macrophages. Exp. Lung Res. 26,41- 56.
Griscavage, J. M., N. E. Rogers, M. P. Sherman, and L. J. Ignarro. 1993. Inducible nitric oxide synthase from a rat alveolar macrophage cell line is inhibited by nitric oxide. J. Immunol. 151:6329-6337.
Geneviève Ménard and Elyse Y. Bissonnette.2000. Priming of Alveolar Macrophages by Leukotriene D4Potentiation of Inflammation. Am. J. Respir. Cell Mol. Biol. Vol.23, pp. 572-577.
Griscavage JM , et al. 1993.Inducible nitric oxide synthase from a rat alveolar macrophage cell line is inhibited by nitric oxide. J. Immunol. 151: 6329-6337.
Griess, P. 1879 Bemerkungen zu der abhandlung der H.H. Weselsky und Benedikt "Ueber einige azoverbindungen". Chem. Ber. 12, 426-8.
Guo L, Li ZS, Wang HL, Ye CY, Zhang DC. Carboxyamido-triazole inhibits proliferation of human breast cancer cells via G(2)/M cell cycle arrest and apoptosis.Eur J Pharmacol. 2006 24;538(1-3):15-22.
Helmke, R. J., V. F. German, and J. A. Mangos. 1989. A continuous alveolar macrophage cell line: comparisons with freshly derived alveolar macrophages. In Vitro Cell. Dev. Biol. 25:44.
Helmke, R. J., R. L. Boyd, V. F. German, and J. A. Mangos. 1987. From growth factor dependence to growth factor responsiveness: the genesis of an alveolar macrophage cell line. In Vitro Cell. Dev. Biol. 23:567.
Hirotsugu Ogura, Yoshinori Tsukumo, Hikaru Sugimoto, Masayuki Igarashi,Kazuo Nagai, Takao Kataoka.2008. Ectodomain shedding of TNF receptor 1 induced by protein synthesis inhibitors regulates TNF-α-mediated activation of NF-κB and caspase-8. EXPERIMENTALCELLRESEARCH 3141406-1414.
Hidalgo HA , et al. 1992.Pneumocystis carinii induces an oxidative burst in alveolar macrophages. Infect. Immun. 60: 1-7.
Hidalgo HA , et al. 1992 .The effects of cyclosporine and dexamethasone on an alveolar macrophage cell line (NR8383). Transplantation 53: 620-623.
Henderson SA , et al. 1994.Nitric oxide reduces early growth response-1 gene expression in rat lung macrophages treated with interferon-gamma and lipopolysaccharide. J. Biol. Chem. 269: 25239-25242.
Huang S , et al. 1992.Rat KC cDNA cloning and mRNA expression in lung macrophages and fibroblasts. Biochem. Biophys. Res. Commun. 184: 922-929.
Huan Lou and Neil Kaplowitz.2007. Glutathione Depletion Down-Regulates Tumor Necrosis Factor (TNF) α-Induced NF-κB Activity via IκB Kinase (IKK)-dependent and -Independent Mechanisms.The Journal of Biological Chemistry.
Han Z, Boyle DL, Chang L,2001 .c-jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis[J]. J Clin Invest, 108(1): 73-8.
Johnson GL, Nakamura K. 2007.The c-jun kinase/stress-activated pathway: regulation,function and role in human disease, Biochim Biophys Acta-Mol Cell Res, 1773(8):1341-1348.
Jong-Bin KIM,Ah-Reum HAN, Eun-Young PARK, Ji-Yeon KIM, Woong CHO,Jun LEE Eun-Kyoung SEO, and Kyung-Tae LEE.2007. Inhibition of LPS-Induced iNOS, COX-2 and Cytokines Expression by Poncirin through the NF-k B Inactivation in RAW 264.7 Macrophage Cells. Biol. Pharm. Bull. 30(12) 2345—2351.
Juyong WANG, Takashi TOKORO, Susumu HIGA, and Isao KITAJIMA.2006.Anti-inflammatory Effect of Pitavastatin on NF-k B Activated by TNF-α in Hepatocellular Carcinoma Cells. Biol. Pharm. Bull. 29(4) 634—639.
John T. Schroeder, PhD, Kristin L. Chichester, MS, and Anja P. Bieneman,BS.2008. Toll-like receptor 9 suppression in plasmacytoid dendritic cells after IgE-dependent activation is mediated by autocrine TNF-α. J Allergy Clin Immunol; 121:486-91.
Krieg DP , et al.1988. Resistance of mucoid Pseudomonas aeruginosa to nonopsonic phagocytosis by alveolar macrophages in vitro. Infect. Immun. 56: 3173-3169.
Kumar S, Singhal V, Roshan R, Sharma A, Rembhotkar GW, Ghosh B.2007.Piperine inhibits TNF-alpha induced adhesion of neutrophils to endothelial monolayer through suppression of NF-kappaB and IkappaB kinase activation. Eur J Pharmacol.
Kinne RW, BrauerR, Stuhlmuller B, et al. 2002. Macrophages in rheumatoid arthritis. [J]. Arthritis Res, 2: 189-202.
Lai Wang,Fenghe Du,and Xiaodong Wang.2008. TNF-a Induces Two Distinct Caspase-8 Activation Pathways. Cell 133, 693-703.
Louisa Y. F. Wong, Bernard M. Y. Cheung, Yuk-Yin Li, and Fai Tang.2005.Adrenomedullin Is Both Proinflammatory and Antiinflammatory: Its Effects on Gene Expression and Secretion of Cytokines and Macrophage Migration Inhibitory Factor in NR8383 Macrophage Cell Line. Endocrinology 146: 1321-1327.
Limper AH , Standing JE . 1994.Vitronectin interacts with Candida albicans and augments organism attachment to the NR8383 macrophage cell line. Immunol. Lett. 42:139-144.
Madhabi Barua,2Yong Liu, and Michael R. Quinn. 2001. Taurine Chloramine Inhibits Inducible Nitric Oxide Synthase and TNF-αGene Expression in Activated Alveolar Macrophages: Decreased NF-κB Activation and IκB Kinase Activity. The Journal of Immunology, 167: 2275-2281.
Manning AM, Davis RJ. 2003.Targeting JNK for therapeutic benefit: from junk to gold?, Nat Rev Drug Discov, 2(7): 554-565.
Michael Karin.2008. The IκB kinase - a bridge between inflammation and cancer. Cell Research 18:334-342.
Norihiro Nishimoto. 2005.Cytokine signal regulation and autoimmune disorders[J].Autoimmunity, 38(5): 359-367.
P. J . HOHENSINNER,C. KAUN, K. RYCHLI, A. NIESSNER, S .PFAFFENBERGER,G. REGA,R. DE MARTIN,G. MAURER,R. ULLRICH, K. HUBER- and J. WOJ TA.2007. Macrophage colony stimulating factor expression in human cardiac cells is upregulated by tumor necrosis factor-a via an NF-κB dependent mechanism. Journal of Thrombosis and Haemostasis, 5: 2520-2528.
Rentian Feng,Gu¨lsu¨mAnderson,Guozhi Xiao, Gary Elliott, Lorenzo Leoni,Markus Y. Mapara,G. David Roodman,and Suzanne Lentzsch.2007. SDX-308, a nonsteroidal anti-inflammatory agent, inhibits NF-κB activity,resulting in strong inhibition of osteoclast formation/activity and multiple myeloma cell growth. Blood;109:2130-2138.
Senftleben Uwe .2007. Anti-inflammatory interventions of NF-κ B signaling: Potential applications and risks. Biochemical pharmacology.
Stadler J,Stefanovic-racic M,Billiar T,et al. 1991 .Articular chondrocytes synthesize nitr ic oxide in response to cytokines and lipopolysaccharide.J Immunol, 147:3915-3920.
Sherman MP, et al. 1993.Pyrrolidine dithiocarbamate inhibits induction of nitric oxide synthase activity in rat alveolar macrophages. Biochem. Biophys. Res. Commun. 191:1301-1308.
S. Perwez Hussain and Curtis C. Harris.2007. Inflammation and cancer: An ancient link with novel potentials. Int. J. Cancer: 121,2373-2380.
Swantek, J.L., Cobb, M.H., Geppert, T.D.1997. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF- α ) translation:glucocorticoids inhibit TNF-a translation by blocking JNK/SAPK. Mol.Cell. Biol. 17, 6274- 6282.
Simmonds RE, Foxwell BM.2008. NF-{kappa}B and its relevance to arthritis and inflammation. Rheumatology.
Vincent Gazin,Saadia Kerdine, Ge＇rard Grillon, Marc Pa Hardy, and Herve＇ Raoul.2004.Uranium induces TNF-asecretion and MAPK activation in a rat alveolar macrophage cell line.Toxicology and Applied Pharmacology 194 (2004) 49- 59.
Wei XQ,CharIes IG,Smith A,et al. 1995.Altered immune responses in mice lacking indu cible nitric oxide synthase.Nature,375:408-411.
Weston CR, Davis RJ. 2007.The JNK signal transduction pathway, Curr Opin Cell Biol,19(2): 142-149.
Yong Liu, Michael R. Quinn. 2002.Chemokine production by rat alveolar macrophages is inhibited by taurine chloramines.Immunology Letters 80(2002) 27-32.
Yao,J.,Mackman,N.,Edgington,T.S.,Fan,S.T.,1997.Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells.J.Biol.Chem.272,17795-17801.
徐叔云,卞如濂,陈修,药理实验方法学(第三版),2002。
[1]Perkins ND.Integrating cell-signalling pathways with NF-kappaB and IKK function[J].Nat Rev Mol Cell Biol,2007,8(1):49-62.
[2]Ahmad R,Raina D,Meyer C,et al.Triterpenoid CDDO-Me blocks the NF-kappaB pathway by direct inhibition ofIKKbeta on Cys-179[J].J Biol Chem,2006,20(2):225-229.
[3]Cheon JH,Kim JS,Kim JM,et al.Plant sterol guggulstero-neinhibits nuclear factor-kappaB signaling in intestinal epi-thelial cells by blocking IkappaB kinase and ameliorates a-cute murine colitis[J].Inflamm Bowel Dis,2006,12(12) :1152-1161 .
[4] Bonello S,Zahringer C. Reactive Oxygen Species Activatethe HIF-1 {alpha}Promoter Via a Functional NF{kappa}B[J] .Site Arterioscler Thromb Vasc Biol, 2007, 12 (2) :24-27 .
[5] Contzler R,Regamey A,Favre B,et al. Histoneacetyl-transferase HBO1 inhibits NF-kappaB activity bcoactiva-torsequestration[J] .Biochem Biophys Res Commun, 2006, 350 (1) :208-213 .
[6] Hacker H, Karin M. Regulation and function of IKK and IKK-related kinases .Sci STKE. 2006,2006 :re13 .
[7] Truhlar SM,Torpey JW,Komives EA. Regions of Ikappa-Balpha that arecritical for its inhibition of NF-kappaB.DNA interaction fold upon binding to NF-kappaB[J].ProcNatl Acad Sci USA, 2006, 103 (50): 18951-18956 .
[8] Saadane A,Didonato J,Li J,et al. Parthenolide Inhibits I{kappa}B Kinase,NF-{kappa}B Activation and Inflam-matory Response in CF Cells and Mice[J] .Am J RespirCell Mol Biol, 2007, 111(21):116-128.
[9] Olajide OA,Heiss EH,Schachner D,et al. Synthetic cryp-tolepine inhibits DNA binding of NF-kappaB[J] .BioorgMed Chem, 2007, 15 (1) :43-49 .
[10] Nishimura D,Ishikawa H,Matsumoto K,et al. DHMEQ,anovel NF-kappaB inhibitor, induces apoptosis and cell-cycle arrest in human hepatoma cells[J] .Immunology, 2006, 115 (3) :348-357.
[11] Ueki S,Yamashita K,Aoyagi T,et al. Control of allograftrejection by applying a novel nuclear factor-kappaB inhibitor,Dehydroxymethylepoxyquinomicin[J].Transplantation, 2006, 82 (12) :1720-1761 .
[12] Greten, F. R. & Karin, M. NF-κB: linking inflammation and immunity to cancer development and progression. Nature Rev. Immunol. 5, 749-759 (2005).
[13]Nizet, V., Lawrence, T. & Karin, M. Innate immunity gone awry: mechanisms linking microbial infections to chronic inflammatory disorders and cancer. Cell 124, 823-835(2006).
[14] Karin, M., Cao, Y., Greten, F. R. & Li, Z. W. NF-κB in cancer: from innocent bystander to major culprit. Nature Rev. Cancer 2, 301-310 (2002).
[15] Li, Q. & Verma, I. M. NF-kB regulation in the immune system. Nature Rev. Immunol.2,725-734 (2002).
[16] El-Omar, E. M. et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404, 398-402 (2000).
[17] Lind, M. H. et al. Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-kB inhibition. Proc. Natl Acad. Sci. USA 101, 4972-4977 (2004).
[18] Pikarsky, E. et al. NF-kB functions as a tumour promoter in inflammation-associated cancer.Nature 431, 461-466 (2004).
[19] Karin, M. & Lin, A. NF-kB at the crossroads of life and death. Nature Immunol. 3, 221-227 (2002).
[20] Chen, L. W. et al. The two faces of IKK and NF-κB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nature Med. 9,575-581
[21] Greten, F. R. et al. IKKβ links inflammation and tumorigenesis in a mouse model of colitisassociated cancer. Cell 118, 285-296 (2004).
[22] Kamata, H. et al. Reactive oxygen species promote TNFa-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120, 649-661 (2005).
[23] Karin, M., Yamamoto, Y. & Wang, Q. M. The IKK NF-kB system: a treasure trove for drug development. Nature Rev. Drug Discov. 3, 17-26 (2004).
[24] Covert, M. W., Leung, T. H., Gaston, J. E. & Baltimore, D. Achieving stability of Lipopolysaccharide-induced NF-κB activation. Science 309, 1854-1857 (2005).
[25] Bonizzi, G. & Karin, M. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25, 280-288 (2004).
[26] Senftleben, U. et al. Activation by IKKa of a second, evolutionary conserved, NF-κB signaling pathway. Science 293, 1495-1499(2001).
Anfernee Kai-Wing Tse, Chi-Keung Wan, Xiao-Ling Shen, Mengsu Yang,Wang-Fun Fong.2005. Honokiol inhibits TNF-α-stimulated NF-κB activation and NF-κB regulated gene expression through suppression of IKK activation. Biochemical Pharmacology 70 (2005) 1443-1457.
Altomonte L, Zoli A, Mirone L. Serum levels of interleukin-1β,tumour necrosis factor-α and interleukin-2 in rheumatoid arthritis. Correlation with disease actibity[J].Clin Rheumatol, 1992,11(2); 202-5.
Amin Majdalawieh, Lei Zhang, and Hyo-Sung Ro.2007. Adipocyte Enhancer-binding Protein-1 Promotes Macrophage Inflammatory Responsiveness by Up-Regulating NF-κB via IκBα Negative Regulation Molecular Biology of the CellVol. 18, 930-942.
Bauer KS, Figg WD, Hamilton JM, Jones EC, Premkumar A, Steinberg SM, Dyer V, Linehan WM, Pluda JM, and Reed E. A pharmacokinetically guided Phase II study of carboxyamido-triazole in androgen-independent prostate cancer. Clin Cancer Res. 1999; 5(9): 2324-2329.
Bauer KS, Cude KJ, Dixon SC, Kruger EA, and Figg WD. Carboxyamido-triazole inhibits angiogenesis by blocking the calcium-mediated nitric-oxide synthase-vascular endothelial growth factor pathway. J. Pharmacol. Exp. Ther. 2000; 292(1): 31-37.
Brennan FM, Maini RN, Feldmann M. Role of pro-inflammatory cytokines in rheumatoid arthritis[J]. Springer Semin Immunopathol, 1998, 20:133-47.
Bredt, D.S. and Snyder, S.H. 1994. Nitric oxide: A physiologic messenger molecule.Ann. Rev. Biochem. 63, 175-95.
Bingle, L., Brown, N. J., and Lewis, C. E. 2002. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol. 196, 254-265.
Bonizzi G, Karin M .2004.The two NF-kappaa activation pathways and their rolein innateand adaptiveimmunity. TrendsInuntmol, 25(6): 280-288.
Bin Liu,Randy Yang, Kelly A. Wong, Crescent Getman,Natalie Stein, Michael A.Teitell,Genhong Cheng, Hong Wu, and Ke Shuai. 2005.Negative Regulation of NF-κB Signaling by PIAS1MOLECULAR AND CELLULAR BIOLOGY, p.1113-1123.
Balkwill F,Mantovani A.2001.Inflammation and cancer:back to Virchow?Lancet,357(9255):539-545.
Coussens LM,Werb Z.2002.Inflammation and cancer.Nature,420(6917):860-867.
Colorado A, Slama JT, Stavinoha WB. A new method for measuring auricular inflammation in the mouse. J Pharmacol Meth 1991,26:73-77.
Chun-Chung Lee, Ko-Jiunn Liu, Li-Li Chen, Yu-Chen Wu, and Tze-Sing Huang.2006. Tumor Necrosis Factor-α, Interleukin-8 and Interleukin-6 Are Involved in Vascular Endothelial Cell Capillary Tube and Network Formation Induced by Tumor-Associated Macrophages Lee et al. J. Cancer Mol. 2(4): 155-160.
Catrin Albrecht, Doris H¨ohr, Petra Haberzettl, and Andrea Becker.2007.Surface-Dependent Quartz Uptake by Macrophages:Potential Role in Pulmonary Inflammation and Lung Clearance. Inhalation Toxicology, 19(Suppl. 1):39—48.
Collart, M.A., Baeuerle, P., Vassalli, P., 1990. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four Kappa B-like motifs and of constitutive and inducible forms of NF-kappa B.Mol. Cell. Biol. 10, 1498-1506.
Christopher Brightling, PhD, MRCP,Mike Berry, MD, MRCP,and Yassine Amrani,PhD.2008. Targeting TNF-a: A novel therapeutic approach for asthma. J Allergy Clin Immunol; 121:5-10.
Dawson, T.M. and Dawson, V.L. 1995. Nitric oxide: Actions and pathological roles. The Neuroscientist 1, 7-18.
De＇rijard, B., Hibi, M., Wu, I.H., Barrett, T., Su, B., Deng, T., Karin, M.,Davis, R.J., 1994. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell ,76, 1025- 1037.
Denholm EM , Rollins SM . 1993.Expression and secretion of transforming growth factor-beta by bleomycin-stimulated rat alveolar macrophages. Am. J. Physiol. 264:L36-L42.
Dayer JM. Interleukin 1 or tumor necrosis factor-alpha: which is the real target in rheumatoid arthritis? J Rheumatol Suppl. 2002 Sep;65:10-5.
Fiddler, R.M. 1977 Collaborative study of modified AOAC method of analysis for nitrite in meat and meat products. J. AOAC 60, 594-9.
Geist, L.J., Powers, L.S., Monick, M.M., Hunninghake, G.W., 2000. Asbestos stimulation triggers differential cytokine release from human monocytes and alveolar macrophages. Exp. Lung Res. 26,41- 56.
Griscavage, J. M., N. E. Rogers, M. P. Sherman, and L. J. Ignarro. 1993. Inducible nitric oxide synthase from a rat alveolar macrophage cell line is inhibited by nitric oxide. J. Immunol. 151:6329-6337.
Geneviève Ménard and Elyse Y. Bissonnette.2000. Priming of Alveolar Macrophages by Leukotriene D4Potentiation of Inflammation. Am. J. Respir. Cell Mol. Biol. Vol.23, pp. 572-577.
Griscavage JM , et al. 1993.Inducible nitric oxide synthase from a rat alveolar macrophage cell line is inhibited by nitric oxide. J. Immunol. 151: 6329-6337.
Griess, P. 1879 Bemerkungen zu der abhandlung der H.H. Weselsky und Benedikt "Ueber einige azoverbindungen". Chem. Ber. 12, 426-8.
Guo L, Li ZS, Wang HL, Ye CY, Zhang DC. Carboxyamido-triazole inhibits proliferation of human breast cancer cells via G(2)/M cell cycle arrest and apoptosis.Eur J Pharmacol. 2006 24;538(1-3):15-22.
Helmke, R. J., V. F. German, and J. A. Mangos. 1989. A continuous alveolar macrophage cell line: comparisons with freshly derived alveolar macrophages. In Vitro Cell. Dev. Biol. 25:44.
Helmke, R. J., R. L. Boyd, V. F. German, and J. A. Mangos. 1987. From growth factor dependence to growth factor responsiveness: the genesis of an alveolar macrophage cell line. In Vitro Cell. Dev. Biol. 23:567.
Hirotsugu Ogura, Yoshinori Tsukumo, Hikaru Sugimoto, Masayuki Igarashi,Kazuo Nagai, Takao Kataoka.2008. Ectodomain shedding of TNF receptor 1 induced by protein synthesis inhibitors regulates TNF-α-mediated activation of NF-κB and caspase-8. EXPERIMENTALCELLRESEARCH 3141406-1414.
Hidalgo HA , et al. 1992.Pneumocystis carinii induces an oxidative burst in alveolar macrophages. Infect. Immun. 60: 1-7.
Hidalgo HA , et al. 1992 .The effects of cyclosporine and dexamethasone on an alveolar macrophage cell line (NR8383). Transplantation 53: 620-623.
Henderson SA , et al. 1994.Nitric oxide reduces early growth response-1 gene expression in rat lung macrophages treated with interferon-gamma and lipopolysaccharide. J. Biol. Chem. 269: 25239-25242.
Huang S , et al. 1992.Rat KC cDNA cloning and mRNA expression in lung macrophages and fibroblasts. Biochem. Biophys. Res. Commun. 184: 922-929.
Huan Lou and Neil Kaplowitz.2007. Glutathione Depletion Down-Regulates Tumor Necrosis Factor (TNF) α-Induced NF-κB Activity via IκB Kinase (IKK)-dependent and -Independent Mechanisms.The Journal of Biological Chemistry.
Han Z, Boyle DL, Chang L,2001 .c-jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis[J]. J Clin Invest, 108(1): 73-8.
Johnson GL, Nakamura K. 2007.The c-jun kinase/stress-activated pathway: regulation,function and role in human disease, Biochim Biophys Acta-Mol Cell Res, 1773(8):1341-1348.
Jong-Bin KIM,Ah-Reum HAN, Eun-Young PARK, Ji-Yeon KIM, Woong CHO,Jun LEE Eun-Kyoung SEO, and Kyung-Tae LEE.2007. Inhibition of LPS-Induced iNOS, COX-2 and Cytokines Expression by Poncirin through the NF-k B Inactivation in RAW 264.7 Macrophage Cells. Biol. Pharm. Bull. 30(12) 2345—2351.
Juyong WANG, Takashi TOKORO, Susumu HIGA, and Isao KITAJIMA.2006.Anti-inflammatory Effect of Pitavastatin on NF-k B Activated by TNF-α in Hepatocellular Carcinoma Cells. Biol. Pharm. Bull. 29(4) 634—639.
John T. Schroeder, PhD, Kristin L. Chichester, MS, and Anja P. Bieneman,BS.2008. Toll-like receptor 9 suppression in plasmacytoid dendritic cells after IgE-dependent activation is mediated by autocrine TNF-α. J Allergy Clin Immunol; 121:486-91.
Krieg DP , et al.1988. Resistance of mucoid Pseudomonas aeruginosa to nonopsonic phagocytosis by alveolar macrophages in vitro. Infect. Immun. 56: 3173-3169.
Kumar S, Singhal V, Roshan R, Sharma A, Rembhotkar GW, Ghosh B.2007.Piperine inhibits TNF-alpha induced adhesion of neutrophils to endothelial monolayer through suppression of NF-kappaB and IkappaB kinase activation. Eur J Pharmacol.
Kinne RW, BrauerR, Stuhlmuller B, et al. 2002. Macrophages in rheumatoid arthritis. [J]. Arthritis Res, 2: 189-202.
Lai Wang,Fenghe Du,and Xiaodong Wang.2008. TNF-a Induces Two Distinct Caspase-8 Activation Pathways. Cell 133, 693-703.
Louisa Y. F. Wong, Bernard M. Y. Cheung, Yuk-Yin Li, and Fai Tang.2005.Adrenomedullin Is Both Proinflammatory and Antiinflammatory: Its Effects on Gene Expression and Secretion of Cytokines and Macrophage Migration Inhibitory Factor in NR8383 Macrophage Cell Line. Endocrinology 146: 1321-1327.
Limper AH , Standing JE . 1994.Vitronectin interacts with Candida albicans and augments organism attachment to the NR8383 macrophage cell line. Immunol. Lett. 42:139-144.
Madhabi Barua,2Yong Liu, and Michael R. Quinn. 2001. Taurine Chloramine Inhibits Inducible Nitric Oxide Synthase and TNF-αGene Expression in Activated Alveolar Macrophages: Decreased NF-κB Activation and IκB Kinase Activity. The Journal of Immunology, 167: 2275-2281.
Manning AM, Davis RJ. 2003.Targeting JNK for therapeutic benefit: from junk to gold?, Nat Rev Drug Discov, 2(7): 554-565.
Michael Karin.2008. The IκB kinase - a bridge between inflammation and cancer. Cell Research 18:334-342.
Norihiro Nishimoto. 2005.Cytokine signal regulation and autoimmune disorders[J].Autoimmunity, 38(5): 359-367.
P. J . HOHENSINNER,C. KAUN, K. RYCHLI, A. NIESSNER, S .PFAFFENBERGER,G. REGA,R. DE MARTIN,G. MAURER,R. ULLRICH, K. HUBER- and J. WOJ TA.2007. Macrophage colony stimulating factor expression in human cardiac cells is upregulated by tumor necrosis factor-a via an NF-κB dependent mechanism. Journal of Thrombosis and Haemostasis, 5: 2520-2528.
Rentian Feng,Gu¨lsu¨mAnderson,Guozhi Xiao, Gary Elliott, Lorenzo Leoni,Markus Y. Mapara,G. David Roodman,and Suzanne Lentzsch.2007. SDX-308, a nonsteroidal anti-inflammatory agent, inhibits NF-κB activity,resulting in strong inhibition of osteoclast formation/activity and multiple myeloma cell growth. Blood;109:2130-2138.
Senftleben Uwe .2007. Anti-inflammatory interventions of NF-κ B signaling: Potential applications and risks. Biochemical pharmacology.
Stadler J,Stefanovic-racic M,Billiar T,et al. 1991 .Articular chondrocytes synthesize nitr ic oxide in response to cytokines and lipopolysaccharide.J Immunol, 147:3915-3920.
Sherman MP, et al. 1993.Pyrrolidine dithiocarbamate inhibits induction of nitric oxide synthase activity in rat alveolar macrophages. Biochem. Biophys. Res. Commun. 191:1301-1308.
S. Perwez Hussain and Curtis C. Harris.2007. Inflammation and cancer: An ancient link with novel potentials. Int. J. Cancer: 121,2373-2380.
Swantek, J.L., Cobb, M.H., Geppert, T.D.1997. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF- α ) translation:glucocorticoids inhibit TNF-a translation by blocking JNK/SAPK. Mol.Cell. Biol. 17, 6274- 6282.
Simmonds RE, Foxwell BM.2008. NF-{kappa}B and its relevance to arthritis and inflammation. Rheumatology.
Vincent Gazin,Saadia Kerdine, Ge＇rard Grillon, Marc Pa Hardy, and Herve＇ Raoul.2004.Uranium induces TNF-asecretion and MAPK activation in a rat alveolar macrophage cell line.Toxicology and Applied Pharmacology 194 (2004) 49- 59.
Wei XQ,CharIes IG,Smith A,et al. 1995.Altered immune responses in mice lacking indu cible nitric oxide synthase.Nature,375:408-411.
Weston CR, Davis RJ. 2007.The JNK signal transduction pathway, Curr Opin Cell Biol,19(2): 142-149.
Yong Liu, Michael R. Quinn. 2002.Chemokine production by rat alveolar macrophages is inhibited by taurine chloramines.Immunology Letters 80(2002) 27-32.
Yao,J.,Mackman,N.,Edgington,T.S.,Fan,S.T.,1997.Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells.J.Biol.Chem.272,17795-17801.
徐叔云,卞如濂,陈修,药理实验方法学(第三版),2002。
[1]Perkins ND.Integrating cell-signalling pathways with NF-kappaB and IKK function[J].Nat Rev Mol Cell Biol,2007,8(1):49-62.
[2]Ahmad R,Raina D,Meyer C,et al.Triterpenoid CDDO-Me blocks the NF-kappaB pathway by direct inhibition ofIKKbeta on Cys-179[J].J Biol Chem,2006,20(2):225-229.
[3]Cheon JH,Kim JS,Kim JM,et al.Plant sterol guggulstero-neinhibits nuclear factor-kappaB signaling in intestinal epi-thelial cells by blocking IkappaB kinase and ameliorates a-cute murine colitis[J].Inflamm Bowel Dis,2006,12(12) :1152-1161 .
[4] Bonello S,Zahringer C. Reactive Oxygen Species Activatethe HIF-1 {alpha}Promoter Via a Functional NF{kappa}B[J] .Site Arterioscler Thromb Vasc Biol, 2007, 12 (2) :24-27 .
[5] Contzler R,Regamey A,Favre B,et al. Histoneacetyl-transferase HBO1 inhibits NF-kappaB activity bcoactiva-torsequestration[J] .Biochem Biophys Res Commun, 2006, 350 (1) :208-213 .
[6] Hacker H, Karin M. Regulation and function of IKK and IKK-related kinases .Sci STKE. 2006,2006 :re13 .
[7] Truhlar SM,Torpey JW,Komives EA. Regions of Ikappa-Balpha that arecritical for its inhibition of NF-kappaB.DNA interaction fold upon binding to NF-kappaB[J].ProcNatl Acad Sci USA, 2006, 103 (50): 18951-18956 .
[8] Saadane A,Didonato J,Li J,et al. Parthenolide Inhibits I{kappa}B Kinase,NF-{kappa}B Activation and Inflam-matory Response in CF Cells and Mice[J] .Am J RespirCell Mol Biol, 2007, 111(21):116-128.
[9] Olajide OA,Heiss EH,Schachner D,et al. Synthetic cryp-tolepine inhibits DNA binding of NF-kappaB[J] .BioorgMed Chem, 2007, 15 (1) :43-49 .
[10] Nishimura D,Ishikawa H,Matsumoto K,et al. DHMEQ,anovel NF-kappaB inhibitor, induces apoptosis and cell-cycle arrest in human hepatoma cells[J] .Immunology, 2006, 115 (3) :348-357.
[11] Ueki S,Yamashita K,Aoyagi T,et al. Control of allograftrejection by applying a novel nuclear factor-kappaB inhibitor,Dehydroxymethylepoxyquinomicin[J].Transplantation, 2006, 82 (12) :1720-1761 .
[12] Greten, F. R. & Karin, M. NF-κB: linking inflammation and immunity to cancer development and progression. Nature Rev. Immunol. 5, 749-759 (2005).
[13]Nizet, V., Lawrence, T. & Karin, M. Innate immunity gone awry: mechanisms linking microbial infections to chronic inflammatory disorders and cancer. Cell 124, 823-835(2006).
[14] Karin, M., Cao, Y., Greten, F. R. & Li, Z. W. NF-κB in cancer: from innocent bystander to major culprit. Nature Rev. Cancer 2, 301-310 (2002).
[15] Li, Q. & Verma, I. M. NF-kB regulation in the immune system. Nature Rev. Immunol.2,725-734 (2002).
[16] El-Omar, E. M. et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404, 398-402 (2000).
[17] Lind, M. H. et al. Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-kB inhibition. Proc. Natl Acad. Sci. USA 101, 4972-4977 (2004).
[18] Pikarsky, E. et al. NF-kB functions as a tumour promoter in inflammation-associated cancer.Nature 431, 461-466 (2004).
[19] Karin, M. & Lin, A. NF-kB at the crossroads of life and death. Nature Immunol. 3, 221-227 (2002).
[20] Chen, L. W. et al. The two faces of IKK and NF-κB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nature Med. 9,575-581
[21] Greten, F. R. et al. IKKβ links inflammation and tumorigenesis in a mouse model of colitisassociated cancer. Cell 118, 285-296 (2004).
[22] Kamata, H. et al. Reactive oxygen species promote TNFa-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120, 649-661 (2005).
[23] Karin, M., Yamamoto, Y. & Wang, Q. M. The IKK NF-kB system: a treasure trove for drug development. Nature Rev. Drug Discov. 3, 17-26 (2004).
[24] Covert, M. W., Leung, T. H., Gaston, J. E. & Baltimore, D. Achieving stability of Lipopolysaccharide-induced NF-κB activation. Science 309, 1854-1857 (2005).
[25] Bonizzi, G. & Karin, M. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25, 280-288 (2004).
[26] Senftleben, U. et al. Activation by IKKa of a second, evolutionary conserved, NF-κB signaling pathway. Science 293, 1495-1499(2001).